Completed OBSERVATIONAL NCT04183322

PCV13 in Non-pregnant Papua New Guinean Women

Reactogenicity and Immunogenicity of Pneumococcal Conjugate Vaccination in Non-pregnant Papua New Guinean Women

Sponsor: Papua New Guinea Institute of Medical Research

Interventions 13-valent pneumococcal conjugate vaccine

Updated 4 times since 2020 Last updated: Dec 13, 2019 Started: May 10, 2016 Primary completion: Sep 14, 2016 Completion: Apr 10, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04183322, this observational or N/A phase trial focuses on Pneumococcal Infections and remains completed. Sponsored by Papua New Guinea Institute of Medical Research, it has been updated 4 times since 2016, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jan 2020 — Jan 2021 [monthly]

Completed

First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Papua New Guinea Institute of Medical Research
Telethon Kids Institute

Data source: Telethon Kids Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Goroka, Papua New Guinea